Aug 2026· Annals of Noninvasive Electrocardiology· Vol 31· 0 citations· 15 references
Medicine
TL;DR
CIED‐detected AF burden is strongly associated with progression to persistent AF, and ML‐based analysis of 6‐month device data enables accurate, point‐in‐time risk stratification to support earlier and more targeted clinical management.
Abstract
ABSTRACT Background Cardiac implantable electronic devices (CIEDs) frequently detect brief, often subclinical atrial fibrillation (AF), but their value for predicting progression to persistent AF remains uncertain. Statistical and machine learning (ML) approaches may enable dynamic risk stratification using this longitudinal device data. Objective To develop a risk stratification model using clinical and CIED‐derived AF burden measured over a rolling 6‐month window to predict progression to persistent AF. Methods We analyzed continuous CIED data from 1985 patients without prior persistent AF implanted between 2016 and 2024 at a tertiary medical center. AF burden and clinical variables were summarized using overlapping 6‐month rolling windows to estimate 1‐year risk of persistent AF. Associations were evaluated using Kaplan–Meier and Cox proportional hazards models. A gradient‐boosted decision tree model (XGBoost) was used to predict progression. Results During a mean follow‐up of 1192 days, 874 patients (44%) developed paroxysmal AF, of whom 257 (29%) progressed to persistent AF after a mean of 813 days. Patients with no AF or < 1 h/day of AF in the prior 6 months had > 97% 1‐year freedom from persistent AF, whereas those with > 8 h/day had a 63% progression rate. Higher AF burden was strongly associated with progression (maximum HR 8.66, p < 0.001). The ML model demonstrated high predictive performance (sensitivity 99.4%, specificity 95.7%). Conclusion CIED‐detected AF burden is strongly associated with progression to persistent AF. ML‐based analysis of 6‐month device data enables accurate, point‐in‐time risk stratification to support earlier and more targeted clinical management.
This data-driven, interpretable XGBoost model enables individualized AF risk assessment in middle-aged and older CHD patients, offering a practical tool for early identification and targeted intervention in clinical practice.
Feng Chen, Qin Fu, Ling Li et al.· Frontiers in Cardiovascular...· 0 citations
A machine learning model integrating perioperative electrocardiographic and clinical variables demonstrated robust performance in predicting the absence of atrial fibrillation at discharge, accurately identifying more than two thirds of patients.
S. Leiler, W. Hitzl, Andre Bauer et al.· Frontiers in Cardiovascular...· 0 citations
External validation of the GLORIA-AF Stroke Weighted Risk Score supports its transportability and potential adjunctive role in guideline-directed thromboembolic risk assessment and generally greater net benefit than CHA2DS2-VA.
In conclusion, AI-derived risk estimates improved physician risk discrimination in a structured simulated survey, particularly in non-specialist settings, supporting their potential role as a digital decision-support tool.
Yeji Kim, Bogeun Kim, J. Yoon et al.· npj Digital Medicine· 0 citations
This study identified eight PerAF-related metabolites via targeted metabolomics and ML, and developed accurate predictive models (including a simplified, clinically feasible model) with favorable predictive performance for PerAF risk stratification.
Pro data from multiple follow-ups, combined with a model constructed using GRU, provides promising tool for predicting mortality risk in patients with chronic heart failure, and the self-developed web-based decision support system allows users to calculate risk scores simply by entering patient information.
Yu-Jia Zhang, Mengyi Dou, Fengqin Ding et al.· Vascular Health and Risk Man...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.